Clinical Trial

Microbial and Cytokine Signatures in Long COVID Patients

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2025 (before its estimated July 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
We aim at identifying potential biomarkers in plasma indicative of post-acute coronavirus SARS-CoV-2 Syndrome (Long COVID). Our case-control study will compare Long COVID patients to healthy patients from Sutter Health.
Trial Details
NCT Number NCT07074158
Lead Sponsor Palo Alto Medical Foundation
Conditions Post-Acute COVID-19 Syndrome
Enrollment 150 participants
Start Date 2025-07-14
Primary Completion 2026-07-13 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-20